A
Aligos Therapeutics
ALGS
0.51110
USD
-0.0019
(-0.37%)
Market Closed
Volume
9,877
EPS
0
Div Yield
0
P/E
-1
Market Cap
30,714,540
Novo Nordisk Surges in Profit and Sales
5 months ago
Stocks newsTitle: Aligos Therapeutics Inc
Sector: Healthcare
Industry: Biotechnology
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.